Furthermore, the higher levels of (histone and MG) glycation adducts in tumour tissues than the normal counterparts, and also that of (MG) glycation adducts in advanced cancers than the localized ones [26, 48], reveal the diagnostic and prognostic implications of AGEs as potential bio-markers besides RAGE with deep clinical prospects. This evidence concerns the gene AGER and neoplasm.